Business
The Food and Drug Administration on Tuesday told Eli Lilly and Novo Nordisk to remove warnings about the risk of suicidal thoughts and behavior from the labels of their blockbuster GLP-1 weight-loss ? [+1275 chars]
Leave A Comment
Comments
No comments yet. Be the first to comment!
